Jan 14 (Reuters) - Cyclopharm Ltd (CYC) :
- USFDA APPROVAL PROGRESS FOR TECHNEGAS AND BUSINESS UPDATE-CYC.AX
- TOTAL UNAUDITED REVENUE FOR 2020 WAS IN LINE WITH PRIOR YEAR AT A$14M
- US FDA APPROVAL TARGETED FOR Q2 ON TRACK WITH PRE‐APPROVAL AUDIT SCHEDULED FOR WEEK COMMENCING 29 MARCH 2021
- FAVOURABLE PROGRESS BEING MADE WITH REGARD TO LITIGATION PROCESS AGAINST FORMER EMPLOYEES
Add to My Watchlist
What is My Watchlist?